 Effect granulocyte colony-stimulating factor neutropenia due non-Hodgkin lymphoma authors recombinant human granulocyte colony-stimulating factor rhG-CSF patients advanced non-Hodgkin lymphoma combination chemotherapy Groups patients day rhG-CSF intravenous infusion days days chemotherapy strong linear relationship dose area curve dose range rhG-CSF serum mean half-life hours second phase patients dose day duration neutropenia duration fever rhG-CSF clinical observation rhG-CSF administration slight bone pain study optimum dose rhG-CSF patients chemotherapy study rhG-CSF useful drug patients myelosuppressive chemotherapy